On M-Net & M-Net HD , Sunday 17 March 2019 at 19:00 & again on M-Net Plus 1  at 20:00
Limpopo Child Gangs
A video showing a group of youngsters kicking and dragging Thoriso Themane emerges, sending shockwaves throughout the country. Themane, a young man from Limpopo, never stood a chance against the group who beat him to death. But was this an isolated incident or the work of a violent gang of children? Carte Blanche investigates whether this is the same gang terrorising the community.
Producer: Ntokozo Miya
Presenter: Macfarlane Moleli
The Last Knysna Elephant
Thousands of elephants once roamed the dense forests of Knysna but over the last 100 years they have been hunted to virtual extinction. For decades, debates have raged on about whether the last-sighted elephant in the forest is one of a family or a single, lone female. Now camera traps, set up along ancient elephant paths, record this heart-breaking story. Carte Blanche joins the tracking team on this remarkable search.
Producer: Liz Fish
Presenter: Derek Watts
Watch the trailer
Lukhanyiso: A Field of Broken Dreams
Carte Blanche investigates the Lukhanyiso Food and Energy Centre in the Free State, which promised emerging farmers a shot at a sustainable future in agriculture and alternative power. Let down by their strategic partner and the Department of Rural Development and Land Reform, the project has been at a standstill, with little to show for the millions of Rands invested. But that didn’t stop the Development Bank of Southern Africa from investing another R60 million in a bio-digester that’s now a white elephant. We ask what went wrong with this flagship project.
Producer: Joy Summers
Presenter: Devi Sankaree Govender
Researcher: Laura Byrne
André Schwartz – Hope for MND
Top Afrikaans artist and leading stage performer of ‘The Sound of Music’ and ‘Phantom of the Opera’, André Schwartz was diagnosed with motor neuron disease last year. Now he’s determined to give science a fighting chance as he embarks on a novel drug therapy that could slow the effects of the disease in its early stages. Edaravone, which is a disease-modifying treatment, previously used for stroke patients, has been approved by America’s FDA as a treatment for MND, for the first time in over two decades. It is expensive and its long-term effects have not been proven, but could this drug provide hope for patients?
Producer: Anna Teichert
Presenter: Claire Mawisa
Watch the trailer
Line-ups are subject to change. Stories can be viewed at www.carteblanche.co.za.